Leukemia Relapse
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT (NCT03793517) | Peking University People's Hospital | 2018-09-01 |
| A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT (NCT03190733) | Zhujiang Hospital | 2017-08-30 |
| Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia (NCT02618109) | University Hospital, Angers | 2016-01-01 |
Track Leukemia Relapse automatically
Every clearance here is in the API, with alerts when new ones post.